New Dosing Guidelines Available: Hizentra for CIDP

In a recent news release, biotherapeutics company CSL Behring shared that the company received FDA approval to update the Hizentra label for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Within…

Continue Reading New Dosing Guidelines Available: Hizentra for CIDP

Clinical Data Shows Guselkumab Efficacy for PsA

  How effective is guselkumab, a human monoclonal antibody, at treating patients with psoriatic arthritis (PsA)? According to post-hoc data analysis from two clinical trials, the therapy was relatively effective.…

Continue Reading Clinical Data Shows Guselkumab Efficacy for PsA

Genetics Linked to Peripartum Cardiomyopathy

Peripartum cardiomyopathy is a rare heart ailment, characterized by a weakened heart muscle, that occurs during pregnancy. But why do some pregnant women develop this condition while others do not?…

Continue Reading Genetics Linked to Peripartum Cardiomyopathy